×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Akari Therapeutics Plc. (AKTX) NASDAQ

$2.84 (0.13) (-4.22%)

Market Cap: $22.46M

As of 06/18/24 04:00 PM EDT. Market closed.

(AKTX)

Akari Therapeutics Plc. (AKTX)
NASDAQ

$2.84
(0.13) (-4.22%)

Market Cap: $22.46M

As of 06/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
24 W 40th St Fl 8, New York, New York, 10018-1028.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
David Solomon
Address
24 W 40th St Fl 8, New York, New York, 10018-1028.
PRICE CHART FOR AKARI THERAPEUTICS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.84
Previous Close
$2.96
Days Range
$2.80 - $2.91
52 week range
$1.08 - $5.50
Volume
12,789
Avg. Volume (30 days)
29,913
Market Cap
$22.46M
Dividend Yield
-
P/E
-
Shares Outstanding
7,923,696
Open
$2.84
Previous Close
$2.96
Days Range
$2.80 - $2.91
52 week range
$1.08 - $5.50
Volume
12,789
Avg. Volume (30 days)
29,913
Market Cap
$22.46M
Dividend Yield
-
P/E
-
Shares Outstanding
7,923,696
FINANCIAL STATEMENTS FOR AKARI THERAPEUTICS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AKARI THERAPEUTICS PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Patel Samir RashmikantDirectorMay 31, 2024 Option Exercise$0.001,326,258,0001,193,6322,147,483,647Jun 04, 2024, 04:45 PM
Prudo-Chlebosz RaymondDirectorMay 31, 2024 Option Exercise$0.001,326,258,0001,193,6322,147,483,647Jun 04, 2024, 04:45 PM
Cohen Mark SDirectorSep 18, 2015 Buy$0.191,055,600200,0361,055,600Sep 22, 2015, 05:42 PM
Cohen Mark SDirectorJan 08, 2015 Option Exercise$0.02202,7003,172152,000Jan 12, 2015, 04:23 PM
SABBY MANAGEMENT, LLC10% OwnerApr 15, 2014 Buy$5.0017,10085,500778,030Apr 17, 2014, 04:17 PM
SABBY MANAGEMENT, LLC10% OwnerApr 14, 2014 Buy$5.213,00015,630760,930Apr 17, 2014, 04:17 PM
SABBY MANAGEMENT, LLC10% OwnerApr 11, 2014 Buy$5.15100515757,930Apr 11, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerApr 10, 2014 Buy$5.251,4007,350757,830Apr 11, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerApr 09, 2014 Buy$5.511,0755,923756,430Apr 11, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerApr 08, 2014 Buy$5.3635,500190,280755,355Apr 08, 2014, 04:05 PM
SABBY MANAGEMENT, LLC10% OwnerApr 07, 2014 Buy$5.7120,654117,840719,855Apr 08, 2014, 04:05 PM
SABBY MANAGEMENT, LLC10% OwnerApr 04, 2014 Buy$6.0712,25074,400699,201Apr 08, 2014, 04:05 PM
SABBY MANAGEMENT, LLC10% OwnerApr 02, 2014 Buy$6.152,50015,375686,951Apr 02, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerApr 01, 2014 Buy$6.1015,37193,806684,451Apr 02, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerMar 17, 2014 Buy$6.652,40015,960661,144Apr 02, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerMar 31, 2014 Buy$6.357,93650,394669,080Apr 02, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerMar 25, 2014 Buy$6.903032,091642,844Mar 27, 2014, 04:15 PM
SABBY MANAGEMENT, LLC10% OwnerMar 27, 2014 Buy$6.611,70011,237658,744Mar 27, 2014, 04:15 PM
SABBY MANAGEMENT, LLC10% OwnerMar 26, 2014 Buy$6.6614,20094,619657,044Mar 27, 2014, 04:15 PM
SABBY MANAGEMENT, LLC10% OwnerMar 24, 2014 Buy$6.712,40016,104642,541Mar 24, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerMar 21, 2014 Buy$6.834,90033,467640,141Mar 24, 2014, 04:04 PM
SABBY MANAGEMENT, LLC10% OwnerMar 20, 2014 Buy$6.903,80026,220635,241Mar 24, 2014, 04:04 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Patel Samir RashmikantDirector05/31/20241,193,632
Prudo-Chlebosz RaymondDirector05/31/20241,193,632
Cohen Mark SDirector09/18/2015200,036
Cohen Mark SDirector01/08/20153,172
SABBY MANAGEMENT, LLC10% Owner04/15/201485,500
SABBY MANAGEMENT, LLC10% Owner04/14/201415,630
SABBY MANAGEMENT, LLC10% Owner04/11/2014515
SABBY MANAGEMENT, LLC10% Owner04/10/20147,350
SABBY MANAGEMENT, LLC10% Owner04/09/20145,923
SABBY MANAGEMENT, LLC10% Owner04/08/2014190,280
SABBY MANAGEMENT, LLC10% Owner04/07/2014117,840
SABBY MANAGEMENT, LLC10% Owner04/04/201474,400
SABBY MANAGEMENT, LLC10% Owner04/02/201415,375
SABBY MANAGEMENT, LLC10% Owner04/01/201493,806
SABBY MANAGEMENT, LLC10% Owner03/17/201415,960
SABBY MANAGEMENT, LLC10% Owner03/31/201450,394
SABBY MANAGEMENT, LLC10% Owner03/25/20142,091
SABBY MANAGEMENT, LLC10% Owner03/27/201411,237
SABBY MANAGEMENT, LLC10% Owner03/26/201494,619
SABBY MANAGEMENT, LLC10% Owner03/24/201416,104
SABBY MANAGEMENT, LLC10% Owner03/21/201433,467
SABBY MANAGEMENT, LLC10% Owner03/20/201426,220
Load More Insider Transactions
FUNDS WITH A POSITION IN AKARI THERAPEUTICS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC14,7690.00004%43.82%Other
BUYBACK ANNOUNCEMENT(S) FOR AKARI THERAPEUTICS PLC
LOADING...